Source:http://linkedlifedata.com/resource/pubmed/id/11478151
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2001-7-31
|
pubmed:abstractText |
A 60-year-old man who had suffered from epigastic pain and general malaise from November 1999 was admitted to our hospital due to Borrmann type 3 gastric cancer with ascites on December 7, 1999. We considered a radical B operation impossible, and placed the patient on neoadjuvant TS-1 chemotherapy consisting of 1 M tegafur, 0.4 M gimestat, and 1 M otastat potassium. There were no side effects other than Grade 1 nausea and mild loss of appetite throughout the chemotherapy. After 8 weeks of administration, the primary lesion was reduced in size, and ascitic fluid had disappeared on abdominal computed tomography images. Therefore, a total gastrectomy with splenectomy and D2 lymph node dissection was performed on March 31, 2000. This was a radical B operation that was not possible earlier. The pathological diagnosis was tub2, SE, N1, CY0, H0, P0, M0, INF gamma, ly1, v1, PM (-), DM (-) and the antitumor efficacy of TS-1 was Grade 2 histologically. The patient remains alive and in good condition with no relapse of the gastric cancer 8 months after surgery.
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites, Antineoplastic,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations,
http://linkedlifedata.com/resource/pubmed/chemical/Oxonic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Pyridines,
http://linkedlifedata.com/resource/pubmed/chemical/S 1 (combination),
http://linkedlifedata.com/resource/pubmed/chemical/Tegafur
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0385-0684
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
999-1002
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11478151-Antimetabolites, Antineoplastic,
pubmed-meshheading:11478151-Ascitic Fluid,
pubmed-meshheading:11478151-Combined Modality Therapy,
pubmed-meshheading:11478151-Drug Administration Schedule,
pubmed-meshheading:11478151-Drug Combinations,
pubmed-meshheading:11478151-Gastrectomy,
pubmed-meshheading:11478151-Humans,
pubmed-meshheading:11478151-Male,
pubmed-meshheading:11478151-Middle Aged,
pubmed-meshheading:11478151-Oxonic Acid,
pubmed-meshheading:11478151-Pyridines,
pubmed-meshheading:11478151-Stomach Neoplasms,
pubmed-meshheading:11478151-Tegafur
|
pubmed:year |
2001
|
pubmed:articleTitle |
[A case of advanced gastric cancer that was resectable after asctic fluid had disappeared following administration of TS-1].
|
pubmed:affiliation |
First Dept. of Surgery, Nagoya City University, Medical School.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Case Reports
|